SCIBASE HOLDING AB (PUBL) |
End-of-day quote
Other stock markets
|
||
| - SEK | - |
|
| Apr. 05 | SciBase Plans SEK48 Million Capital Raising for Commercialization, Growth in US | MT |
| Feb. 28 | SciBase to Offer Diagnostic Tool on Skinobs Cosmetic Testing Platform | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
SciBase Holding AB is a Sweden-based company engaged in the medical equipment industry. The Company specializes in the manufacture of point of care device, called Nevisense, which is aimed to detect of malignant melanoma. Nevisense analyze suspicious lesions by using Electrical Impedance Spectroscopy (EIS) which is applied as an electrical signal to the skin. The diagnostic product is sold in Nordic countries, Belgium, Germany, Great Britain and Australia.
Calendar
2024-05-08
- Q1 2024 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| -12.91% | 19.08B | |
| -46.21% | 2.65B | |
| +18.15% | 1.87B | |
| -3.12% | 1.61B | |
| +23.78% | 1.21B | |
| -10.69% | 1.02B | |
| -20.89% | 905M | |
| -18.10% | 682M | |
| -7.14% | 716M |
- Stock Market
- Equities
- Stock
- News SciBase Holding AB (publ)
- SciBase : Diagnostic Tool Nevisense Shows Potential in Detecting Atopic Dermatitis; Shares Surge 21%
